Portola, Daiichi Sankyo deal

Portola partnered with Daiichi to conduct a Phase IIa trial to evaluate the safety and efficacy of Portola's andexanet alfa ( PRT4445) in reversing the anticoagulation effects of Daiichi's edoxaban in...